Several studies have demonstrated the expression of IL1Ra to be positively correlated with progression and lymph node metastasis (47–49), inhibit IL-1 mediated prostate cancer regression (50), and increased growth rate of glioblastoma cells (51). The gene discussed is IL1RN; the disease is metastatic malignant neoplasm in the lymph nodes.